CJC-1295 / Ipamorelin (Injectable)
Growth & anti-aging
The pepti Pen cartridge for this treatment is sold out right now. The vial is the same medication at our best price.
All-in monthly price
No membership fee · this is the full price · free shipping · avg 4-week supply
Add in-depth bloodwork
Optional — add a physician-reviewed at-home blood panel to your plan.
Your sex-hormone baseline plus the safety markers that matter on therapy — blood counts, liver and kidney function — from one painless upper-arm device. Matched to your sex (PSA for men; progesterone & FSH for women). No needle, no clinic, physician-reviewed.
This treatment requires licensed provider review and approval. Treatment is not guaranteed. If prescribed, medication is fulfilled by a licensed U.S. pharmacy where permitted by law. Compounded medications are not FDA-approved or FDA-cleared.
Reviewed by Dr. Gene, MD · Board-certified Family Medicine
Every Pepti prescription is reviewed by a licensed U.S. physician before it's dispensed — and only provided if clinically appropriate.
CJC-1295 / Ipamorelin (Injectable)
Growth hormone releasing combo that promotes deep sleep, recovery, and cellular regeneration.
About a 4-week supply supply at the standard prescribed dose — your physician confirms exact dosing.
A licensed US physician reviews your intake and prescribes when appropriate.
Compounded fresh at a US pharmacy and shipped cold-chain to your door.
Every order ships free — medication, physician care and refills, one all-in price.
Amounts shown are per unit. Compounded fresh at a US FDA-registered pharmacy.
Every batch independently tested
Every medication batch dispensed through Pepti is independently tested by a qualified third-party laboratory for applicable quality and safety standards before the pharmacy releases it. Batches are tested to the same standard used by 503B outsourcing facilities.
Confirms the finished preparation is free of viable microorganisms.
Screens for endotoxins that can cause fever or inflammatory reactions.
Verifies the labeled concentration of the active peptide is what is in the vial.
Checks the active peptide against impurities and degradation products.
Confirms the peptide in the vial is the correct molecule.
Confirms the solution sits within the range specified for injection.
Checks the finished vial for visible and sub-visible particles.
Confirms the vial seal holds so sterility is maintained through the beyond-use date.
How CJC-1295 / Ipamorelin is prescribed.
- Adults seeking growth-hormone support through the body's own pulsatile release
- Patients focused on sleep quality, recovery, and body composition
- People who want a gentler growth-hormone peptide than tesamorelin
Your physician decides whether CJC-1295 / Ipamorelin is appropriate for you after reviewing your intake and labs.
Inject 0.25 mL (25 units) subcutaneously once daily Monday through Friday on an empty stomach.
- Licensed physician review of your intake, history, and labs
- Medication compounded to your prescription by a PCAB-accredited, FDA-registered pharmacy
- Every batch independently tested before release
- Sterile syringes and alcohol prep pads for injectables
- Tracked delivery to your door, refills on schedule
- Message your physician anytime; dose changes without an appointment
- Store refrigerated (36–46°F / 2–8°C) at all times, including before first use.
- One vial is your monthly supply. A fresh vial ships every 28 days on your refill schedule, so you're always well inside the beyond-use date on your label.
- Protect from light. Wipe the stopper with an alcohol pad before every draw.
- Dispose of syringes in the sharps container per the included instructions.
A typical course of CJC-1295 / Ipamorelin.
Everything published
about CJC-1295 / Ipamorelin.
How it is described to work, pathway by pathway. What the research shows and what it does not. Where it stands with the FDA, dated and sourced.
Read the referencepeer-reviewed, each verified on PubMed
mechanism, evidence, dosing, safety, FAQ
2026 · checked against fda.gov, not memory
How CJC-1295 / Ipamorelin works, and what the research shows.
CJC-1295 is a GHRH analog that extends growth hormone release duration.
Ipamorelin is a selective GH secretagogue that triggers clean GH pulses without raising cortisol or prolactin.
Together they produce sustained, physiological GH elevation.
In a placebo-controlled study in healthy adults, single doses of CJC-1295 raised growth hormone output and IGF-1 for six or more days.
Teichman et al., J Clin Endocrinol Metab 2006Ipamorelin was characterized as the first selective ghrelin-receptor agonist — stimulating GH release without meaningful cortisol or prolactin elevation.
Raun et al., Eur J Endocrinol 1998The combination is a standard pairing in GH-peptide practice, though long-term outcome trials of the combo itself have not been conducted.
References
- Teichman SL, Neale A, Lawrence B et al.. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults · J Clin Endocrinol Metab (2006) · PMID 16352683
- Raun K, Hansen BS, Johansen NL et al.. Ipamorelin, the first selective growth hormone secretagogue · Eur J Endocrinol (1998) · PMID 9849822
- Ionescu M, Frohman LA. Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog · J Clin Endocrinol Metab (2006) · PMID 17018654
- Alba M, Fintini D, Sagazio A et al.. Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse · Am J Physiol Endocrinol Metab (2006) · PMID 16822960
- Gobburu JV, Agersø H, Jusko WJ et al.. Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers · Pharm Res (1999) · PMID 10496658
- Johansen PB, Nowak J, Skjaerbaek C et al.. Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in rats · Growth Horm IGF Res (1999) · PMID 10373343
- Svensson J, Lall S, Dickson SL et al.. The GH secretagogues ipamorelin and GH-releasing peptide-6 increase bone mineral content in adult female rats · J Endocrinol (2000) · PMID 10828840
- Venkova K, Mann W, Nelson R et al.. Efficacy of ipamorelin, a novel ghrelin mimetic, in a rodent model of postoperative ileus · J Pharmacol Exp Ther (2009) · PMID 19289567
- Beck DE, Sweeney WB, McCarter MD et al.. Prospective, randomized, controlled, proof-of-concept study of the Ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients · Int J Colorectal Dis (2014) · PMID 25331030
- Van Cauter E, Leproult R, Plat L. Age-related changes in slow wave sleep and REM sleep and relationship with growth hormone and cortisol levels in healthy men · JAMA (2000) · PMID 10938176
- Blackman MR, Sorkin JD, Münzer T et al.. Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial · JAMA (2002) · PMID 12425705
- Giannoulis MG, Sonksen PH, Umpleby M et al.. The effects of growth hormone and/or testosterone in healthy elderly men: a randomized controlled trial · J Clin Endocrinol Metab (2006) · PMID 16332938
- Nackeeran S, Kohn T, Gonzalez D et al.. The Effect of Route of Testosterone on Changes in Hematocrit: A Systematic Review and Bayesian Network Meta-Analysis of Randomized Trials · J Urol (2022) · PMID 34445892
- Veldhuis JD, Bowers CY. Determinants of GH-releasing hormone and GH-releasing peptide synergy in men · Am J Physiol Endocrinol Metab (2009) · PMID 19240251
- Kim SH, Park MJ. Effects of growth hormone on glucose metabolism and insulin resistance in human · Ann Pediatr Endocrinol Metab (2017) · PMID 29025199
- Jetté L, Léger R, Thibaudeau K et al.. Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog · Endocrinology (2005) · PMID 15817669
- Sackmann-Sala L, Ding J, Frohman LA, Kopchick JJ. Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects · Growth Horm IGF Res (2009) · PMID 19386527
- Yuen KCJ, Biller BMK, Radovick S, et al.. American Association of Clinical Endocrinologists and American College of Endocrinology guidelines for management of growth hormone deficiency in adults and patients transitioning from pediatric to adult care · Endocrine Practice (2019) · PMID 31760824
- Clemmons DR. Consensus statement on the standardization and evaluation of growth hormone and insulin-like growth factor assays · Clin Chem (2011) · PMID 21285256
- Sigalos JT, Pastuszak AW. The Safety and Efficacy of Growth Hormone Secretagogues · Sex Med Rev (2018) · PMID 28400207
- Renehan AG, Zwahlen M, Minder C et al.. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis · Lancet (2004) · PMID 15110491
- Liu H, Bravata DM, Olkin I, Nayak S, Roberts B. Systematic review: the safety and efficacy of growth hormone in the healthy elderly · Annals of Internal Medicine (2007) · PMID 17227934
- Guevara-Aguirre J, Balasubramanian P, Guevara-Aguirre M et al.. Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans · Sci Transl Med (2011) · PMID 21325617
- Grunstein RR, Handelsman DJ, Lawrence SJ et al.. Neuroendocrine dysfunction in sleep apnea: reversal by continuous positive airways pressure therapy · J Clin Endocrinol Metab (1989) · PMID 2493027
- Harman SM, Metter EJ, Tobin JD et al.. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging · J Clin Endocrinol Metab (2001) · PMID 11158037
- Wu FC, Tajar A, Beynon JM et al.. Identification of late-onset hypogonadism in middle-aged and elderly men · N Engl J Med (2010) · PMID 20554979
- Liu H, Bravata DM, Olkin I et al.. Systematic review: the effects of growth hormone on athletic performance · Ann Intern Med (2008) · PMID 18347346
- Meinhardt U, Nelson AE, Hansen JL et al.. The effects of growth hormone on body composition and physical performance in recreational athletes: a randomized trial · Ann Intern Med (2010) · PMID 20439575
- Van Cauter E, Plat L, Copinschi G. Interrelations between sleep and the somatotropic axis · Sleep (1998) · PMID 9779515
Citations are provided for educational purposes. They do not constitute medical advice. Always discuss any peptide protocol with your prescribing physician.
Important safety information
+
Possible side effects
Do not use if you have
If you experience severe side effects, call 911 or go to your nearest emergency room.
5 mL multi-dose vial, CJC-1295 1.2 mg/mL + Ipamorelin 2.4 mg/mL (6 mg CJC-1295 / 12 mg Ipamorelin per vial); as the Pen: 3 mL pre-filled Pen cartridge containing 1.5 mg CJC-1295 + 6 mg Ipamorelin
Frequently asked
about CJC-1295 / Ipamorelin (Injectable).
Growth hormone releasing combo that promotes deep sleep, recovery, and cellular regeneration. CJC-1295 / Ipamorelin is prescription-only at Pepti: a licensed physician reviews your assessment and, if appropriate, prescribes it to be compounded by a state-licensed, FDA-registered pharmacy.
CJC-1295 / Ipamorelin is $239 per month at Pepti as a vial, or $339 as a pre-filled pepti Pen. That is all-in: medication, physician review and ongoing care, shipping, and messaging. No membership, consult, or visit fees, and the price is the same in every state.
CJC-1295 / Ipamorelin is commonly prescribed for: Adults seeking growth-hormone support through the body's own pulsatile release; Patients focused on sleep quality, recovery, and body composition; People who want a gentler growth-hormone peptide than tesamorelin. Whether it is appropriate for you is decided by the reviewing physician from your history, medications, and labs where required.
Yes. CJC-1295 / Ipamorelin is prescription-only. The free online assessment takes about five minutes, a physician licensed in your state reviews it within 4 hours, and if approved the prescription goes to the pharmacy. If not approved, the medication charge is refunded.
Yes. CJC-1295 / Ipamorelin is one of the medications Pepti requires recent bloodwork for before it is prescribed. Upload a recent lab report from any lab, or order Pepti's at-home panel; the physician reviews the results with your assessment.
CJC-1295 / Ipamorelin is a subcutaneous injection into the abdomen or thigh with a small insulin syringe. Your kit ships with sterile syringes and alcohol prep pads, and the exact dose and schedule are printed on the pharmacy label. Dosing videos are in your account. It is also available as a pre-filled pepti Pen for $339.
33 more questions about Pepti, answered.Show fewer
One vial is your monthly supply at the dose your physician prescribes. A fresh vial ships about every 28 days, and the date moves if your physician changes your dose. Store it as the pharmacy label directs, refrigerated.
Once per fill, $239 each time, when the next vial ships. It renews until you cancel, which you can do anytime from your account with no cancellation fee.
The compounded CJC-1295 / Ipamorelin with sterile syringes and alcohol prep pads, free tracked shipping in an unbranded box with insulated packaging, the physician review, ongoing physician care and dose adjustments, and unlimited messaging.
Reported side effects of CJC-1295 / Ipamorelin are usually mild: mild redness or swelling at injection site; temporary fatigue or headache; mild nausea (uncommon); slight tingling on first dose (normal); vivid dreams. The physician screens your history, medications, and allergies before prescribing, the medication-specific consent lists the known risks, and you can message your physician about anything you notice. Seek emergency care for severe symptoms.
Response varies by person, goal, and dose, and CJC-1295 / Ipamorelin is prescribed for ongoing use rather than a short trial. Your physician sets expectations at approval, tracks how you respond through your account, and adjusts the dose without an appointment.
Yes. Request it from your account or the app; your physician approves or declines. If approved you pay for the additional medication at the pharmacy's cost and the new dose applies to your next shipment.
Yes. Add CJC-1295 / Ipamorelin to a plan with another treatment and both go through one assessment and one physician review, shipping together on one schedule. Each keeps its own catalog price. The physician reviews the combination and can adjust it.
No. Compounded CJC-1295 / Ipamorelin is not FDA-approved. It is prepared to your physician's prescription by a state-licensed, FDA-registered 503A pharmacy and every batch is independently tested before release.
Yes, when prescribed by a licensed physician and dispensed by a licensed pharmacy, which is how Pepti provides it in every state it serves. Research-use-only CJC-1295 / Ipamorelin sold without a prescription is labeled not for human use and is a different product.
CJC-1295 is a GHRH analog that extends growth hormone release duration. At Pepti it is prescribed to support better sleep, anti-aging, muscle recovery, body composition. Individual response varies, and your physician sets expectations at approval.
CJC-1295 is a GHRH analog that extends growth hormone release duration. Ipamorelin is a selective GH secretagogue that triggers clean GH pulses without raising cortisol or prolactin. Together they produce sustained, physiological GH elevation. Compounded CJC-1295 / Ipamorelin is not FDA-approved; it is prescribed off-label by a licensed physician after reviewing your assessment.
CJC-1295 / Ipamorelin is prescribed for better sleep, anti-aging, muscle recovery, body composition. It is commonly requested by adults seeking growth-hormone support through the body's own pulsatile release; patients focused on sleep quality, recovery, and body composition; people who want a gentler growth-hormone peptide than tesamorelin. Whether it is appropriate for you is the reviewing physician's decision.
CJC-1295 / Ipamorelin is studied for better sleep, anti-aging, muscle recovery, body composition. Those are the goals it is prescribed to support at Pepti; results vary by person, dose, and consistency, and no outcome is guaranteed. Your physician tracks how you respond through your account.
In a placebo-controlled study in healthy adults, single doses of CJC-1295 raised growth hormone output and IGF-1 for six or more days (Teichman et al., J Clin Endocrinol Metab 2006). Ipamorelin was characterized as the first selective ghrelin-receptor agonist — stimulating GH release without meaningful cortisol or prolactin elevation (Raun et al., Eur J Endocrinol 1998). The combination is a standard pairing in GH-peptide practice, though long-term outcome trials of the combo itself have not been conducted. References are listed on this page.
CJC-1295 / Ipamorelin is generally not prescribed with: active cancer or history of cancer (unless approved by oncologist); pregnancy or breastfeeding; severe kidney or liver disease; known allergy to the peptide or excipients. The physician screens for these in your intake, and anything that rules CJC-1295 / Ipamorelin out means it is not prescribed and is refunded.
At Pepti. Complete the free assessment, a physician licensed in your state reviews it within 4 hours, and if appropriate CJC-1295 / Ipamorelin is compounded by a state-licensed, FDA-registered pharmacy and shipped free to your door for $239 per month, all-in. Not prescribed means refunded.
Injectable vial: 5 mL, containing 6 mg CJC-1295 + 12 mg Ipamorelin. Pepti Pen cartridge: 3 mL cartridge (300 units), containing 1.5 mg CJC-1295 + 6 mg Ipamorelin. One vial is your monthly supply at the prescribed dose, and a fresh one ships about every 28 days.
Yes. CJC-1295 / Ipamorelin is available as a pre-filled pepti Pen cartridge for $339 per month, versus $239 as a vial. Same medication, same pharmacy; the reusable injector is free with your first pen order. Choose the format in the cart or ask your physician.
$239 per month covers the compounded CJC-1295 / Ipamorelin, the physician review, ongoing physician care including dose adjustments and refill review, unlimited messaging, and free tracked shipping. There is no membership, consult, visit, or refill fee; the only separate charges are optional at-home lab panels and a physician-approved dose increase billed at pharmacy cost.
Yes. CJC-1295 / Ipamorelin is on Pepti's live catalog, which lists only treatments a partner pharmacy can compound and ship today. If a physician prescribes it, it ships; if it ever cannot be dispensed, the charge is refunded.
CJC-1295 / Ipamorelin ships to 50 states, free and tracked, in insulated unbranded packaging. Eligibility is confirmed during the assessment from your shipping address.
$239 per month at Pepti as a vial, or $339 as a pepti Pen. That includes the compounded CJC-1295 / Ipamorelin, the physician review and ongoing care, free tracked shipping, and messaging, with no membership, consult, or visit fee. The price is the same in every state and every refill is the same price.
Yes. Pepti offers CJC-1295 / Ipamorelin as a pre-filled pepti Pen cartridge for $339 per month, or as a vial for $239. The reusable injector is included free with your first pen order and tips come with every cartridge. Same medication, same pharmacy, physician-prescribed after a free online assessment.
Yes. Pepti prescribes CJC-1295 / Ipamorelin online in 50 states after a free assessment reviewed by a physician licensed in your state. It is compounded by an FDA-registered pharmacy and shipped free, $239 per month all-in. Not prescribed means refunded.
Yes. At Pepti the entire process is telehealth: a five-minute online assessment, recent bloodwork from any lab or an at-home panel, physician review within 4 hours, then CJC-1295 / Ipamorelin ships from the pharmacy. No clinic visit and no video appointment in most cases. $239 per month, all-in.
Yes, for the real thing. CJC-1295 / Ipamorelin sold without a prescription is research-use-only product labeled not for human use, with no physician, no pharmacy, and no verified testing. Pepti's CJC-1295 / Ipamorelin is physician-prescribed, pharmacy-compounded, batch-tested, and $239 per month including the physician and shipping.
Pepti does, in 50 states, with named board-certified physicians, a state-licensed FDA-registered compounding pharmacy, independent batch testing, and one published all-in price of $239 per month with no membership or consult fee. Refunded if the physician does not prescribe.
It is legal to be prescribed CJC-1295 / Ipamorelin online by a licensed physician and have it dispensed by a licensed pharmacy, which is how Pepti provides it. Buying it as a research chemical without a prescription is a different product and is not for human use. Compounded CJC-1295 / Ipamorelin is not FDA-approved.
$239 per month at Pepti, or $339 as a pepti Pen, including the medication, the physician, and shipping. Refills are the same price and there is no membership fee.
Yes. Pepti has no clinics: the assessment, physician review, messaging, dose changes, and refills all happen online, and CJC-1295 / Ipamorelin ships free from the pharmacy to your door in 50 states.
Start the free assessment at hellopepti.com, choose CJC-1295 / Ipamorelin, and answer the health questions and upload recent labs or order the at-home panel. A physician licensed in your state reviews it within 4 hours. If approved, CJC-1295 / Ipamorelin ships within 1-3 business days and arrives in 1-3 more; if not, the $239 is refunded.
Yes. CJC-1295 / Ipamorelin is one of the medications Pepti requires recent bloodwork for. Upload a lab report from any lab, or order a Pepti at-home panel from $129; the physician reviews it with your assessment.
Pepti ships CJC-1295 / Ipamorelin to 50 states, free and tracked, refrigerated in insulated packaging, directly from the pharmacy. Delivery is 1-3 business days after the pharmacy compounds it.
Questions people ask
about CJC-1295 / Ipamorelin (Injectable).
- CJC-1295 / Ipamorelin: What It Is, Where to Get It Prescribed, and What It CostsCJC-1295 / Ipamorelin — 5 mL multi-dose vial, CJC-1295 1.2 mg/mL + Ipamorelin 2.4 mg/mL (6 mg CJC-1295 / 12 mg Ipamorelin per vial). Specification, mechanism, dosing, formats, state availability and how to get it prescribed.
- CJC-1295 vs Sermorelin: Duration, Dosing, Cost and Which to ChooseA head-to-head comparison of the two GHRH analogues: how each works, how long each lasts, what they are paired with, the side-effect profile, price, and who suits which.
- Peptides for Longevity and Anti-Aging: What Is Actually Prescribed and What the Evidence SaysThe peptides used in longevity protocols, what each one does at the cellular level, which claims outrun the evidence, and what it costs.
- How Much Do Peptides Cost? Real Monthly Prices and What Drives ThemWhat prescription peptides actually cost per month, why single molecules price differently from four-peptide blends, which costs providers hide behind a low headline, and how to compare.
- Do You Need a Doctor to Get Peptides? Yes, and Here Is Exactly WhyPeptides used clinically are prescription medications. Why a prescriber is legally required, what your own doctor will likely say, and what a real review looks like online.
- How to Inject Peptides Safely: Step by Step, Units, Sites and MistakesA practical subcutaneous injection walkthrough: reading your sig, converting millilitres to insulin-syringe units, the ten steps, site rotation, what to do about bubbles and missed doses.
Read more about CJC-1295 / Ipamorelin (Injectable).
Ready to start with CJC-1295 / Ipamorelin (Injectable)?
Free assessment. Licensed physicians. Money-back guarantee if not approved.
In your pocket.
Message your medical team, track every order, chart every lab marker. 5.0 on the App Store.
Get the app
PCAB-accredited pharmacies on every order.
Every fulfillment runs through a PCAB-accredited pharmacy.
See the lab results
- Rigorous third-party quality & safety inspections
- Cleanliness and sterile processes
- Proper ingredient sourcing
- Accurate dosing and formulation
- Staff training and procedures
- Accredited by NABP & ACHC